Carter Bankshares Statistics
Total Valuation
CARE has a market cap or net worth of $534.28 million. The enterprise value is $305.96 million.
Important Dates
The last earnings date was Thursday, April 23, 2026, before market open.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CARE has 22.16 million shares outstanding. The number of shares has decreased by -2.82% in one year.
| Current Share Class | 22.16M |
| Shares Outstanding | 22.16M |
| Shares Change (YoY) | -2.82% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 3.91% |
| Owned by Institutions (%) | 47.88% |
| Float | 20.05M |
Valuation Ratios
The trailing PE ratio is 5.01 and the forward PE ratio is 11.30.
| PE Ratio | 5.01 |
| Forward PE | 11.30 |
| PS Ratio | 2.06 |
| Forward PS | 2.92 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 2.84 |
| EV / Sales | 1.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.86%.
| Return on Equity (ROE) | 23.86% |
| Return on Assets (ROA) | 2.28% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.69% |
| Revenue Per Employee | $376,885 |
| Profits Per Employee | $156,921 |
| Employee Count | 687 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CARE has paid $30.73 million in taxes.
| Income Tax | 30.73M |
| Effective Tax Rate | 22.12% |
Stock Price Statistics
The stock price has increased by +57.14% in the last 52 weeks. The beta is 0.44, so CARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +57.14% |
| 50-Day Moving Average | 22.06 |
| 200-Day Moving Average | 19.80 |
| Relative Strength Index (RSI) | 63.68 |
| Average Volume (20 Days) | 320,245 |
Short Selling Information
The latest short interest is 1.02 million, so 4.59% of the outstanding shares have been sold short.
| Short Interest | 1.02M |
| Short Previous Month | 1.10M |
| Short % of Shares Out | 4.59% |
| Short % of Float | 5.07% |
| Short Ratio (days to cover) | 4.55 |
Income Statement
In the last 12 months, CARE had revenue of $258.92 million and earned $107.81 million in profits. Earnings per share was $4.81.
| Revenue | 258.92M |
| Gross Profit | 258.92M |
| Operating Income | 145.24M |
| Pretax Income | 138.90M |
| Net Income | 107.81M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $4.81 |
Full Income Statement Balance Sheet
The company has $228.32 million in cash and n/a in debt, with a net cash position of $228.32 million or $10.30 per share.
| Cash & Cash Equivalents | 228.32M |
| Total Debt | n/a |
| Net Cash | 228.32M |
| Net Cash Per Share | $10.30 |
| Equity (Book Value) | 504.90M |
| Book Value Per Share | 22.78 |
| Working Capital | -4.00B |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | 56.09% |
| Pretax Margin | 53.64% |
| Profit Margin | 41.78% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CARE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.82% |
| Shareholder Yield | 2.82% |
| Earnings Yield | 20.18% |
| FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for CARE is $25.00, which is 3.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 3.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |